Skip to content

electroCore, Inc. ECOR Accrued Research And Development Expenses Current

Accrued Research And Development Expenses Current at other companies

Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$2.04M-63.7%
Assembly Biosciences logo
Assembly BiosciencesASMB
$1.54M-27.0%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$12.47M+17.7%
Alumis Inc. logo
Alumis Inc.ALMS
$35.96M+3.6%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$4.4M+73.5%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$5.74M+23.5%

Other financials

Income statement

See full
Revenue$9.6M+42.6%
Gross profit$8.4M+46.6%
Operating income-$5.3M-39.1%
Net income-$5.3M-36.7%
EPS (diluted)-$0.59-25.5%

Balance sheet

See full
Cash & equivalents$4.9M+20.5%
Total debt$9.5M+127%
Total equity-$5.7M-230%
Total assets$15.5M-3.5%

Cash flow

See full
Operating cash flow-$3.0M+30.9%
CapEx$2.0K-94.6%
Free cash flow-$3.0M+31.5%

Valuation

See full
Market cap$71.67M+81.6%
Enterprise value$76.31M+90.2%
P/S2.1×+0.6×

Profitability

See full
Gross margin87.2%+2.0pp
Operating margin-42%-3.3pp
Net margin-44.1%-2.0pp
FCF margin-19.7%

Returns & leverage

See full
Return on equity-210.6%+125pp
Debt / equity3.8×+3.5×
Current ratio-0.5×

Where this comes from

Reported directly by electroCore, Inc. in its filing.

Tagged under the XBRL concept ECOR:AccruedResearchAndDevelopmentExpensesCurrent.

The official record: electroCore, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about electroCore, Inc.'s accrued research and development expenses current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is electroCore, Inc.'s accrued research and development expenses current?
electroCore, Inc. (ECOR) reported accrued research and development expenses current of $655K in Q1 2026.
How has electroCore, Inc.'s accrued research and development expenses current changed year-over-year?
electroCore, Inc.'s accrued research and development expenses current decreased by 0.0% year-over-year, from $655K to $655K.
What does accrued research and development expenses current mean?
This represents the current liability for research and development activities that have been performed but not yet invoiced or paid. It captures the accrual of costs associated with clinical trials, product development, or scientific research initiatives. This metric is a key indicator of the company's ongoing investment in innovation and future product pipelines.